Use of restrictive iron transfusion strategy in inflammatory bowel disease: one size does not fit all

Authors’ reply to ‘Use of restrictive iron transfusion strategy in IBD: one size does not fit all’

“…Giri et al [1] addressed a few key issues in our work, underlining that 'one size does not fit all', and, based on our results, we completely agree: indeed, we concluded our paper, suggesting that an on-demand strategy in delivering FCM may be considered not for all patients, but in those with a good response to FCM infusion after 3 months, as they may not need further iron supplementation.…”

“…We thank Dr. Giri and colleagues [1] for their interest in our work regarding ferric carboxymaltose (FCM) delivery strategy in patients with inflammatory bowel disease (IBD).…”